The FDA proposed a new tactic in its fight against the opioid epidemic — blister packs of smaller quantities of opioid drugs that could give providers better prescription options, especially…
The FDA warned Young Health Products for marketing drug products on its website that are not safe and effective for their promoted uses. Source: Drug Industry Daily
Vical announced its restructuring late Tuesday. Source: BioSpace
MannKind could be sent to dilute shares in a significant manner, warns Maxim analyst Jason Kolbert in a research note released today. Source: BioSpace
The bill would allow access to experimental treatments for patients with terminal conditions. Source: BioSpace
The company is now waiting for the FDA to determine a path forward in resuming clinical studies. Source: BioSpace
The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace
A look at three big biotech companies that have big catalysts this year that could have a, you guessed it, big effect. Source: BioSpace
The new data supports further development of SAGE-217 in disorders associated with disruption of normal sleep. Source: BioSpace
It seems that the primary news surrounding Alzheimer's disease research has been nothing but negative for years. Source: BioSpace